Vijay Kumar
Stock Analyst at Evercore ISI Group
(3.33)
# 1,064
Out of 4,667 analysts
187
Total ratings
50.57%
Success rate
1.28%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXAS Exact Sciences | Maintains: Outperform | $80 → $60 | $52.70 | +13.85% | 3 | Nov 6, 2024 | |
| USB U.S. Bancorp | Maintains: In-Line | $51 → $54 | $50.74 | +6.42% | 4 | Oct 30, 2024 | |
| SYK Stryker | Maintains: Outperform | $380 → $384 | $385.68 | -0.44% | 9 | Oct 30, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $630 → $620 | $512.84 | +20.90% | 10 | Oct 24, 2024 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $475 → $490 | $541.82 | -9.56% | 11 | Oct 18, 2024 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $183 → $185 | $181.58 | +1.88% | 5 | Oct 16, 2024 | |
| BLCO Bausch + Lomb | Upgrades: Outperform | $19 → $25 | $19.38 | +29.00% | 7 | Oct 15, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $113 → $110 | $109.27 | +0.67% | 12 | Oct 1, 2024 | |
| WAT Waters | Maintains: In-Line | $335 → $355 | $357.77 | -0.77% | 8 | Oct 1, 2024 | |
| TWST Twist Bioscience | Maintains: Outperform | $52 → $56 | $41.11 | +36.22% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $21 → $18 | $16.86 | +6.76% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $1,375 → $1,450 | $1,166.90 | +24.26% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $98.59 | +62.29% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $104 | $84.11 | +23.65% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $78 → $82 | $78.04 | +5.07% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $102 | $84.90 | +20.14% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $76 → $70 | $69.54 | +0.66% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $58 | $44.78 | +29.52% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $278 | $233.10 | +19.26% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $82 → $90 | $90.17 | -0.19% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $222.39 | +30.40% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $53 → $50 | $44.65 | +11.98% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $124 | $115.93 | +6.96% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $135 → $145 | $128.57 | +12.78% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4.5 → $5 | $3.81 | +31.23% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $45 | $32.63 | +37.91% | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $20.14 | +34.06% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $195 → $175 | $131.68 | +32.90% | 6 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $111.34 | +12.27% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.90 | +677.78% | 1 | May 31, 2022 |
Exact Sciences
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $60
Current: $52.70
Upside: +13.85%
U.S. Bancorp
Oct 30, 2024
Maintains: In-Line
Price Target: $51 → $54
Current: $50.74
Upside: +6.42%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $380 → $384
Current: $385.68
Upside: -0.44%
Thermo Fisher
Oct 24, 2024
Maintains: Outperform
Price Target: $630 → $620
Current: $512.84
Upside: +20.90%
Intuitive Surgical
Oct 18, 2024
Maintains: In-Line
Price Target: $475 → $490
Current: $541.82
Upside: -9.56%
J.B. Hunt Transport Services
Oct 16, 2024
Maintains: Outperform
Price Target: $183 → $185
Current: $181.58
Upside: +1.88%
Bausch + Lomb
Oct 15, 2024
Upgrades: Outperform
Price Target: $19 → $25
Current: $19.38
Upside: +29.00%
Zimmer Biomet Holdings
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $109.27
Upside: +0.67%
Waters
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $357.77
Upside: -0.77%
Twist Bioscience
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $41.11
Upside: +36.22%
Oct 1, 2024
Maintains: In-Line
Price Target: $21 → $18
Current: $16.86
Upside: +6.76%
Oct 1, 2024
Maintains: In-Line
Price Target: $1,375 → $1,450
Current: $1,166.90
Upside: +24.26%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $98.59
Upside: +62.29%
Oct 1, 2024
Maintains: Outperform
Price Target: $100 → $104
Current: $84.11
Upside: +23.65%
Oct 1, 2024
Maintains: In-Line
Price Target: $78 → $82
Current: $78.04
Upside: +5.07%
Oct 1, 2024
Maintains: Outperform
Price Target: $98 → $102
Current: $84.90
Upside: +20.14%
Oct 1, 2024
Maintains: In-Line
Price Target: $76 → $70
Current: $69.54
Upside: +0.66%
Oct 1, 2024
Maintains: Outperform
Price Target: $62 → $58
Current: $44.78
Upside: +29.52%
Oct 1, 2024
Maintains: Outperform
Price Target: $275 → $278
Current: $233.10
Upside: +19.26%
Oct 1, 2024
Maintains: Outperform
Price Target: $82 → $90
Current: $90.17
Upside: -0.19%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $222.39
Upside: +30.40%
Oct 1, 2024
Maintains: In-Line
Price Target: $53 → $50
Current: $44.65
Upside: +11.98%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $124
Current: $115.93
Upside: +6.96%
Oct 1, 2024
Maintains: In-Line
Price Target: $135 → $145
Current: $128.57
Upside: +12.78%
Aug 7, 2024
Maintains: In-Line
Price Target: $4.5 → $5
Current: $3.81
Upside: +31.23%
Jul 2, 2024
Maintains: Outperform
Price Target: $46 → $45
Current: $32.63
Upside: +37.91%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $20.14
Upside: +34.06%
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $131.68
Upside: +32.90%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $111.34
Upside: +12.27%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.90
Upside: +677.78%